Skip to main content
PBF logo

PBF — Investor Relations & Filings

Ticker · 1760 ISIN · TW0001760007 LEI · 54930078VUU2LBPR2729 TW Manufacturing
Filings indexed 1,559 across all filing types
Latest filing 2024-03-07 Regulatory Filings
Country TW Taiwan
Listing TW 1760

Panion & BF Biotech Inc. is a biotechnology company focused on pharmaceutical research, development, and manufacturing. Founded in 1976, the firm operates across several core sectors, including new drug innovation, medical aesthetics, and nutritional supplements. It is recognized for its "Total Aging Management" strategy, which addresses the health needs of an aging population through a diverse product portfolio. Key offerings include treatments for chronic kidney disease, specifically phosphate binders, as well as dermatological drugs, hair care solutions, and rapid diagnostic technologies. The company integrates clinical-grade pharmaceutical standards into its consumer health and aesthetic products, serving markets in chronic disease care and preventative wellness.

Recent filings

Filing Released Lang Actions
113年2月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a financial disclosure from a listed company, 寶齡富錦, providing data on fund lending balances and endorsement guarantees for the current and previous month, including limits and cumulative amounts. The content is concise (613 characters) and focuses on specific financial data related to capital lending and guarantees, without broader financial statements or management discussion. It does not present a full financial report, earnings release, or management commentary. It is a regulatory disclosure of financial information related to capital and guarantees, which fits best under Regulatory Filings (RNS) as it is a general regulatory announcement and does not fit other more specific categories.
2024-03-07 Chinese
113年2月營業收入
Fund Information / Factsheet Classification · 95% confidence The document is a summary report of monthly and cumulative net operating revenue figures for a company named 寶齡富錦, presented in a tabular format with percentage changes compared to the previous year. It includes notes explaining accounting standards and reporting practices related to IFRS and financial industry specifics. The document length is very short (770 characters), and it does not contain detailed financial statements, management discussion, or comprehensive analysis. It is essentially a brief financial data summary, likely a monthly revenue report or a financial fact sheet. Given the short length and nature of the content, it does not qualify as a full Interim/Quarterly Report (IR) or Annual Report (10-K). It is also not an announcement of a report publication. The best fitting category is Fund Information / Factsheet (FS), which covers brief summaries of key company financials and market info.
2024-03-07 Chinese
公告本公司董事會決議股利分派
Notice of Dividend Amount Classification · 100% confidence The document is a short announcement (777 characters) from a company (寶齡富錦) disclosing the board of directors' resolution on dividend distribution. It includes details such as dividend amounts per share, total cash dividend, and the relevant fiscal year. There is no detailed financial report or analysis, only the announcement of dividend decisions. According to the classification rules, announcements of dividend amounts and payment details fall under the category 'Notice of Dividend Amount (DIV)'. The document is not a full report but a formal announcement of dividend distribution.
2024-03-07 Chinese
公告本公司董事會決議通過112年度財務報告
Regulatory Filings Classification · 95% confidence The document is a company announcement from the board of directors regarding the approval of the annual financial report for the fiscal year 112 (2023). It includes summarized financial data such as revenue, gross profit, operating profit, net profit, total assets, liabilities, and equity for the full year period 112/01/01 to 112/12/31. The document is short (904 characters) and appears to be a formal announcement of the board's resolution to approve the annual financial report rather than the full annual report itself. There is no detailed financial statement or comprehensive analysis present, only key financial figures and approval dates. Therefore, this document is best classified as a Regulatory Filing (RNS) because it is an official announcement of the board's approval of the annual financial report, not the full Annual Report (10-K) itself.
2024-03-07 Chinese
公告本公司董事會決議召開本公司113年股東常會
AGM Information Classification · 95% confidence The document is a company announcement regarding the board of directors' resolution to convene the Annual General Meeting (AGM) for the year 113 (Taiwan calendar year). It includes details such as the date and location of the AGM, the agenda items including reports, approvals, and discussions to be held at the meeting. The document does not contain the actual AGM materials or presentations but is an announcement of the AGM meeting and its agenda. The document length is short (1001 characters), and it serves as a notice rather than the full AGM report or presentation. Therefore, it fits the category of AGM Information (AGM-R).
2024-03-07 Chinese
112年度股利金額(董事會決議)
Notice of Dividend Amount Classification · 95% confidence The document contains detailed information about dividend distribution, including cash dividends per share, dates of board resolutions, shareholder meeting dates, and explanations of dividend policies. It is focused on the announcement of dividend amounts and related shareholder distribution details. The document length is relatively short (2033 characters) and it primarily serves as an announcement of dividend amounts rather than a full financial report or other types of filings. Therefore, it fits the category of Notice of Dividend Amount (DIV).
2024-03-07 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.